Loading clinical trials...
Loading clinical trials...
Safety And Efficacy Of Weekly Administration Of S-8184 Paclitaxel Injectable Emulsion In Second Line Treatment Of Patients With Locally Advanced, Metastatic, Or Recurrent Transitional Cell Carcinoma Of The Urothelium
Conditions
Interventions
S-8184 Paclitaxel Injectable Emulsion
Experimental Arm: TOCOSOL Paclitaxel
Start Date
April 1, 2002
Primary Completion Date
September 1, 2007
Completion Date
September 1, 2007
Last Updated
June 4, 2009
NCT07481851
NCT06680089
NCT06237920
NCT04579380
NCT05887245
NCT03081858
Lead Sponsor
Achieve Life Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions